Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other financing activities (2016 - 2024)

Historic Other financing activities for Anaptysbio (ANAB) over the last 7 years, with Q4 2024 value amounting to $122000.0.

  • Anaptysbio's Other financing activities rose 38372.09% to $122000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $492000.0, marking a year-over-year increase of 5045.87%. This contributed to the annual value of $492000.0 for FY2024, which is N/A changed from last year.
  • Anaptysbio's Other financing activities amounted to $122000.0 in Q4 2024, which was up 38372.09% from $334000.0 recorded in Q3 2024.
  • Over the past 5 years, Anaptysbio's Other financing activities peaked at $334000.0 during Q3 2024, and registered a low of -$290000.0 during Q4 2022.
  • For the 3-year period, Anaptysbio's Other financing activities averaged around $61500.0, with its median value being $39500.0 (2023).
  • The largest annual percentage gain for Anaptysbio's Other financing activities in the last 5 years was 205000.0% (2023), contrasted with its biggest fall of 8517.24% (2023).
  • Anaptysbio's Other financing activities (Quarter) stood at -$290000.0 in 2022, then surged by 85.17% to -$43000.0 in 2023, then soared by 383.72% to $122000.0 in 2024.
  • Its Other financing activities stands at $122000.0 for Q4 2024, versus $334000.0 for Q3 2024 and $36000.0 for Q2 2024.